Clinical trial
Observational Study to Define Patient Preferences Toward the Attributes of Treatment Used for Inflammatory Bowel Disease, Including Efficacy Profile, Safety Profile, Frequency and Route of Administration, in Europe
NCT04597905 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Study to Define Patient Preferences Toward the Attributes of Treatment Used for Inflammatory Bowel Disease, Including Efficacy Profile, Safety Profile, Frequency and Route of Administration, in Europe
- Lead sponsor
- Takeda
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 21, 2020
- Completion date
- January 31, 2021
- Enrollment
- 686 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.